{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:07:11Z","timestamp":1772824031557,"version":"3.50.1"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1097\/fpc.0000000000000041","type":"journal-article","created":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T10:22:37Z","timestamp":1393928557000},"page":"272-275","source":"Crossref","is-referenced-by-count":2,"title":["No influence of CYP3A43 rs472660G>A on steady-state serum olanzapine concentrations in White psychiatric patients"],"prefix":"10.1097","volume":"24","author":[{"given":"Mao M.","family":"S\u00f6derberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Espen","family":"Molden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marja-Liisa","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210213","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.","volume":"8","author":"De Hert","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"R2-6-20210213","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00007691-200302000-00007","article-title":"Therapeutic drug monitoring of olanzapine: the combined effect of age, gender, smoking, and comedication.","volume":"25","author":"Gex-Fabry","year":"2003","journal-title":"Ther Drug Monit"},{"key":"R3-6-20210213","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2217\/pgs.13.120","article-title":"Pharmacogenetics of olanzapine metabolism.","volume":"14","author":"Soderberg","year":"2013","journal-title":"Pharmacogenomics"},{"key":"R5-6-20210213","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/tpj.2012.47","article-title":"Influence of FMO1 and 3 polymorphisms on serum olanzapine and its N-oxide metabolite in psychiatric patients.","volume":"13","author":"Soderberg","year":"2013","journal-title":"Pharmacogenomics J"},{"key":"R6-6-20210213","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/FPC.0b013e3283602876","article-title":"Influence of CYP1A1CYP1A2 and AHR polymorphisms on systemic olanzapine exposure.","volume":"23","author":"Soderberg","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"R7-6-20210213","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2125.1996.tb00180.x","article-title":"In vitro interaction of the antipsychotic agent olanzapine with human cytochromes P450 CYP2C9, CYP2C19, CYP2D6 and CYP3A.","volume":"41","author":"Ring","year":"1996","journal-title":"Br J Clin Pharmacol"},{"key":"R8-6-20210213","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/mp.2011.38","article-title":"Genetic variation in CYP3A43 explains racial difference in olanzapine clearance.","volume":"16","author":"Bigos","year":"2011","journal-title":"Mol Psychiatry"},{"key":"R10-6-20210213","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1038\/psp.2013.14","article-title":"Basic concepts in population modeling, simulation, and model-based drug development - part 2: introduction to pharmacokinetic modeling methods.","volume":"2","author":"Mould","year":"2013","journal-title":"CPT Pharmacometrics Syst Pharmacol"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FPC.0000000000000041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:21:56Z","timestamp":1620951716000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-201405000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0000000000000041","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}